INVO Bioscience Reports Second Quarter 2021 Financial and Operating Results and Provides Business Update

Aug 16, 2021 | Press Releases

Company to Host Conference Call Today at 4:30pm ET (Details Below)SARASOTA, Fla., Aug. 16, 2021 — INVO Bioscience, Inc. (Nasdaq: INVO), a medical device company focused on creating alternative treatments for patients diagnosed with infertility and developers of...

INVO Bioscience to Report Second Quarter 2021 Financial Results on Monday, August 16, 2021

Aug 5, 2021 | Press Releases

Financial results to be released after market close; Conference call to be conducted at 4:30 pm ETSARASOTA, Fla., Aug. 5, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo Culture...

INVO Bioscience Announces First Joint-Venture Grand Opening Scheduled for August 9, 2021 in Birmingham, Alabama

Aug 2, 2021 | Press Releases

Innovative Fertility Specialists, An INVO Center becomes the first JV-owned clinic focused on providing INVOcell to assist the underserved patients in need of advanced fertility careSARASOTA, Fla., Aug. 2, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO), a...

INVO Bioscience Appoints Barbara Levy as Senior VP, Global Clinical Integration

Jul 14, 2021 | Press Releases

Joins INVO Bioscience to accelerate INVOcell’s global OB/GYN clinical integration strategySARASOTA, Fla., July 14, 2021 – INVO Bioscience, Inc. (NASDAQ: INVO), a medical device company focused on commercializing the world’s only in vivo Culture...

INVO Bioscience Signs Joint Venture Agreement with Bloom Fertility to Open an INVOcell Fertility Clinic in Atlanta

Jun 30, 2021 | Press Releases

INVO Bioscience and established reproductive specialist Dr. Sue Ellen Carpenter, MD of Bloom Fertility today announce their partnership to make INVOcell, an innovative technology that allows early embryo development to take place within the woman’s body, more...